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Yersinia pseudotuberculosis binds to b1 integrin receptors, and uses the type III secretion proteins YopB and YopD to
introduce pores and to translocate Yop effectors directly into host cells. Y. pseudotuberculosis lacking effectors that
inhibit Rho GTPases, YopE and YopT, have high pore forming activity. Here, we present evidence that Y.
pseudotuberculosis selectively modulates Rho activity to induce cellular changes that control pore formation and
effector translocation. Inhibition of actin polymerization decreased pore formation and YopE translocation in HeLa
cells infected with Y. pseudotuberculosis. Inactivation of Rho, Rac, and Cdc42 by treatment with Clostridium difficile
toxin B inhibited pore formation and YopE translocation in infected HeLa cells. Expression of a dominant negative form
of Rac did not reduce the uptake of membrane impermeable dyes in HeLa cells infected with a pore forming strain
YopEHJT
-. Similarly, the Rac inhibitor NSC23766 did not decrease pore formation or translocation, although it
efficiently hindered Rac-dependent bacterial uptake. In contrast, C. botulinum C3 potently reduced pore formation and
translocation, implicating Rho A, B, and/or C in the control of the Yop delivery. An invasin mutant (Y.
pseudotuberculosis invD911E) that binds to b1 integrins, but inefficiently transduces signals through the receptors,
was defective for YopE translocation. Interfering with the b1 integrin signaling pathway, by inhibiting Src kinase
activity, negatively affected YopE translocation. Additionally, Y. pseudotuberculosis infection activated Rho by a
mechanism that was dependent on YopB and on high affinity bacteria interaction with b1 integrin receptors. We
propose that Rho activation, mediated by signals triggered by the YopB/YopD translocon and from engagement of b1
integrin receptors, stimulates actin polymerization and activates the translocation process, and that once the Yops are
translocated, the action of YopE or YopT terminate delivery of Yops and prevents pore formation.
Citation: Mejı ´a E, Bliska JB, Viboud GI (2008) Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog 4(1): e3. doi:10.1371/journal.
ppat.0040003
Introduction
A great spectrum of Gram-negative bacteria depends on a
specialized secretion mechanism to establish a successful
infection in the host. This machinery is known as the type III
secretion system (TTSS), and is present in organisms that are
pathogenic for animals or plants, as well as in symbiotic
bacteria [1]. In pathogenic Yersinia species, a TTSS is encoded
in a large virulence plasmid, and is required for counter-
acting innate and adaptive host immune defenses [2]. This is
accomplished by injection of six effector proteins (YopE,
YopT, YopH, YopJ, YopO, YopM) that target different host
cell signaling molecules. This injection mechanism is known
as Yop translocation.
Two effectors relevant to this work are YopE and YopT,
which target a family of Rho GTPases that control a variety of
cellular functions, including regulation of the actin cytoskel-
eton. In turn, the activity of the Rho GTPases is tightly
controlled by a number of regulators. Guanine nucleotide
exchange factors (GEFs) induce activation of GTPases by
inducing GDP/GTP exchange. GTPase accelerating proteins
(GAPs) inactivate Rho GTPases by stimulating GTP hydrol-
ysis. Active Rho proteins are mostly associated with cellular
membranes by means of a post-translational lipid modiﬁca-
tion (prenylation) [3]. YopE inhibits RhoGTPases by acting as
a GAP for RhoA, Rac1, or Cdc42 [4,5]. YopT inhibits
preferably RhoA, by cleaving the isoprenyl group and
removing the GTPase from the membrane [6].
Although the mechanism of translocation is not completely
understood, it is thought that effectors are delivered from the
bacterial cytoplasm to the outer membrane through a
secretion conduit. In turn, this channel is connected to a
needle–like structure that transports the effectors directly
into the host cell’s cytoplasm. Apart from the proteins that
form the needle, three translocator proteins (YopB, YopD
and LcrV) are required for the delivery of toxins into the host
cell. YopB and YopD are thought to form a translocation
channel at the plasma membrane [7–9]. Two recent report
show that LcrV is located at the tip of the needle [10], and
that it may act as an assembly platform for YopB and YopD
prior to their insertion in the membrane [11].
Activation upon contact of the bacteria with the host cell is
one of the hallmarks of the TTSS. Adhesion of Yersinia to host
cells is mediated by surface proteins, such as invasin or YadA
binding to b1 integrin host cell receptors, or by pH6 antigen
interacting with glycosphingolipids [12,13]. High afﬁnity
interaction of b1 integrin receptor with invasin, or YadA
(via ﬁbronectin), stimulates a signal transduction pathway
that involves activation of Src protein tyrosine kinase,
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FAK and Cas, and downstream activation of Rac1 and PI3-K
[12,14,15]. Stimulation of this pathway results in bacterial
internalization.
We have previously shown that infection of epithelial cells
with Y. pseudotuberculosis lacking YopE, YopT, YopJ and YopH
elicits a proinﬂammatory signaling response that requires
YopB but is independent of YopD, suggesting that this
signaling event can occur in the absence of a translocation
channel [16]. This proinﬂammatory response, characterized by
activation of MAP kinases and NFjB, and production of IL-8,
is blocked by the Rho GTPase inhibitory action of YopE, and
to a lesser extent YopT [17]. It is therefore possible that YopB
elicits activation of a signaling pathway involving Rho GTPases.
Although a translocation channel composed of YopB and
YopD is thought to insert into the host cell membrane, the
integrity of the plasma membrane remains intact during
infection with wild type Yersinia. However, infection with
Yersinia mutant strains that do not produce YopE and YopT
results in loss of membrane integrity, a process known as pore
formation [7,18]. Interestingly, yopE,yopT mutants also induce
the polymerization of an actin ring at the site of the
interaction with the host cell, but the link between these
‘‘actin halos’’ and pore formation is not known. How YopE or
YopT prevent pore formation is not fully understood, and is a
controversial issue [19]. We have found that, catalytically
inactive forms of YopE or YopT ([18], unpublished data) were
not able to prevent pore formation, analyzed by uptake of
impermeable dyes (EtdBr) or release of lactate dehydrogenase
(LDH). Expression of constitutively active forms of RhoA or
Rac1 prior to infection, rescued the pore forming activity of
bacteria expressing YopE or YopT [18]. In addition, infection
carried out in the presence of actin polymerization inhibitors
dramatically reduced pore formation. Based on these results
we concluded that insertion of the YopB/D translocation
channel results in Rho GTPases activation, actin polymer-
ization, and pore formation [18]. Here, we present evidence
that not only pore formation but most importantly, trans-
location is controlled by Rho activity and actin polymer-
ization. We also found that high afﬁnity interaction between
YadA or invasin with b1 integrin receptors is crucial for
efﬁcient translocation of Yops. Thus, we hypothesize that
YopB/D signaling, in cooperation with b1 integrin signaling,
activates Rho to induce changes in the host cell cytoskeleton
that control the translocation process.
Results
YopB/D-Mediated Pore Formation Is Independent of
Caspase-1 Activation
Macrophages infected with Salmonella or Shigella species
undergo a caspase-1-dependent form of cell death termed
pyroptosis [20]. This death mechanism is proinﬂammatory,
and requires Yersinia YopB homologues SipB and IpaB, from
Salmonella and Shigella, respectively. A recent report shows
that pyroptosis is caused by caspase-1-dependent pore
formation and consequent osmotic lysis [21]. Pore formation
is usually determined by the incorporation or release of
membrane impermeable dyes, such as EtdBr and BCECF,
respectively, by the infected cells [7,8,22]. Because pore
formation is followed by osmotic lysis, an indirect method
to determine pore formation involves measuring the release
of the cytoplasmic enzyme lactate dehydrogenase (LDH) in
supernatants of cultured cells [22]. In Yersinia-infected
macrophages, caspase-1-mediated maturation and release of
the proinﬂammatory cytokine interleukin 1b can be inhibited
by YopE and YopT [23]. Because the inhibitory action of
YopE and YopT on the Rho GTPases also blocks pore
formation [18], we investigated whether YopB/D-mediated
cell lysis in HeLa cells is a result of caspase-1 mediated cell
death. We used Ac-YVAD-cmk (YVAD), a permeable peptide
that speciﬁcally inhibits caspase-1, irreversibly. HeLa cells
treated for 1 h with 50 lM or 100 lM of YVAD, or control
untreated cells, were infected with pore forming strain
yopEHJ (YP27), and the corresponding pore forming-deﬁcient
strain that lacks YopB (yopEHJB, YP29). The uptake of the
impermeable dye ethidium homodimer-2 (EthD2) and the
amount of LDH released in the supernatant of infected cells
was tested 3 hours after infection. YVAD did not prevent
LDH release (Figure 1A) or penetration of the dye (not
shown) in cells infected with YP27. On the other hand, YVAD
treatment dramatically inhibited YP27-induced IL-1b pro-
duction in J774.1A macrophage-like cells (Figure S1), indicat-
ing that 100lM YVAD efﬁciently inhibits caspase-1 mediated
processes. These data support the hypothesis that YopB/D-
mediated loss of membrane integrity in epithelial cells does
not require caspase-1 activation.
Salmonella–induced pyroptosis is also inhibited by 5 mM
glycine [20]. We investigated if YopB/D-induced loss of
membrane integrity could be inhibited by treatment with 5
mM glycine through out the infection. As shown in Figure 1B,
glycine had no effect on the amount of LDH released by
YP27-infected cells. This result further suggests that in HeLa
cells YopB/D-mediated LDH release occurs by a process
different from pyroptosis. We therefore consider that, in our
experimental system, pore formation is linked to the trans-
location process.
Rho GTPase Activation Promotes Pore Formation and Yop
Translocation
We have previously found that pore formation is prevented
by the catalytic activity of two Rho GTPase-inhibiting
effectors, YopE and YopT [18]. To test whether inactivation
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Author Summary
The type III secretion system (TTSS) is essential for the virulence of a
number of Gram-negative human pathogens of enormous clinical
significance. The molecular mechanisms by which TTSS effector
proteins are translocated into the host cell are not well understood.
The work presented here proposes a new model in which the
enteropathogen Yersinia pseudotuberculosis manipulates the host
cell machinery to control effector translocation. This involves
activation of the host cell Rho GTPase by the cooperative action
of adhesin-mediated high affinity binding to specific cell receptor
molecules known as b1 integrins, and interaction of components of
the TTSS with the host cell membrane. This molecular mechanism of
controlling TTSS may not be restricted to Y. pseudotuberculosis and
might take place during infection of host cells with other pathogens
that encode homologues of Yersinia TTSS proteins. Our findings
provide a good starting point to study the molecular nature of the
complex interaction between bacterial pathogens bearing TTSSs
and the host cell. Importantly, components that act by modulating
the TTSS are potential targets for novel antimicrobials.ofsmallGTPasesinhibitsporeformation,weincubatedcellsfor
2 h in the presence or absence of 40ng/ml of Clostridium difﬁcile
toxin B (ToxB), an ADP-ribosylating protein that powerfully
inhibits Rho, Rac and Cdc42. ToxB treatment strongly reduced
the uptake of ethidium homodimer-2 (EthD-2) by cells infected
with pore forming strain yopEHJ (YP27) (Figure 2A). Rho
GTPase downregulation by ToxB also inhibited LDH release
(Figure 2B). Thus supernatants of YP27-infected cells treated
with ToxB released levels of LDH comparable to those of cells
infected withthe pore-forming-deﬁcientstrainyopEHJB(YP29).
These data suggest that YopB/D-mediated pore formation
requires activation of Rho GTPases.
Figure 1. Effect of Caspase-1 Inhibitor or Glycine on YopB/D-Mediated LDH Release
HeLa cells were left untreated or treated with 50 lM or 100 lM caspase-1 inhibitor Ac-YVAD-cmk one hour before infection (A) or through out the
infection with 5mM glycine (B). After 3 h infection with a yopEHJ mutant (YP27) or yopEHJB mutant (YP29), culture supernatants were removed and
tested for LDH release using CytoTox 96 assay kit (Promega). The percentage of LDH release was calculated by dividing the amount of LDH release from
infected cells by the amount of LDH release from uninfected cells lysed by a freeze-thaw cycle. Error bars represent the standard deviation of the mean
values obtained from three infected wells.
doi:10.1371/journal.ppat.0040003.g001
Figure 2. Effect of ToxB or Cytochalasin D on Pore Formation and Yop Translocation
HeLa cells were left untreated, exposed to 40ng/ml C. difficile Toxin B (ToxB), or 3.9lM cytochalasin D (CD) for 2 hours prior to infection. Cells on
coverslips were infected with yopEHJ mutant (YP27) or yopEHJB mutant (YP29) for 3 h, and stained with DEAD-LIVE kit, as described in Material and
Methods. Cells with disrupted membranes exhibit a red nuclei staining (A). LDH release was determined in the culture supernatants 3h post infection
(B). Wild type (YP126) and yopB mutant (YP18) were used to infect Hela cells for 2 hours. Triton X-100 cell lysates were centrifuged, and soluble and
insoluble fractions (containing translocated Yops and bacterial Yops, respectively) were analyzed by immunoblotting using anti-YopE antibodies. Anti-b
actin antibody was used as a loading control of the soluble fraction. Anti-rabbit antibodies conjugated with IR800 or IR680 were used as secondary
antibodies, and the infrared signal was detected using the Li-Cor Odyssey infrared scanner. The intensity of each band was calculated using the
software provided by the Odyssey IR imaging system, and the YopE/b-actin ratios were plotted on a graph (C).
doi:10.1371/journal.ppat.0040003.g002
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form of YopE (YopER144A) is translocated at higher levels
than wild type YopE [4,18]. Aili et al. have also reported this
phenomenon recently; they showed that several YopE
mutants defective for GAP activity are hypertranslocated
[24,25] . Interestingly, Wong and Isberg [26] observed that
overexpression of YopT inhibits YopE translocation. Alto-
gether, these observations suggest a possible role of GTPase
activation in controlling the translocation process. To study
this hypothesis we tested the action of ToxB on YopE
translocation using the Triton X-100 solubility assay de-
scribed in Material and Methods. Pretreatment of HeLa cells
with ToxB reduced the amount of YopE translocated by wild
type strain YP126 by 60% (Figure 2C). As expected, only
background levels of YopE were detected in the soluble
fraction of cells infected with the translocation deﬁcient
YopB
- mutant, YP18. The inhibitory effect of ToxB on pore
formation and translocation is not likely to be a consequence
of an impairment of the bacteria-host cell interaction,
because the number of cell-associated bacteria did not vary
with ToxB treatment (Figure S2). This led us to conclude that
Yop translocation is strongly inﬂuenced by the level of Rho,
Rac or Cdc42 activation.
Inhibition of Actin Polymerization Decreases Yop
Translocation
In previous experiments, we have shown that actin
polymerization inhibitors, cytochalasin D (CD) and latruncu-
lin B, inhibit pore formation [18]. Here we conﬁrmed the
effect of CD on pore formation (Figures 2A and 2B), and
determined whether host actin polymerization plays a role in
Yop translocation during Yersinia infection. As shown in
Figure 2C, CD treatment greatly reduced the amount of
translocated YopE, this inhibitory effect being comparable to
the ToxB treatment. Adhesion assays showed that CD does
not affect the number of cell-associated bacteria greatly (not
shown). These observations appear to indicate that actin
polymerization is not only required for pore formation, as we
had shown previously, but it also controls Yop translocation.
Invasin- or YadA-Mediated Adhesion Promotes Pore
Formation and Yop Translocation
Y. pseudotuberculosis internalization into epithelial cells
requires a signaling cascade that results from the binding of
invasin or YadA to b1 integrin receptors. Bacterial uptake
requires small Rho GTPases activation and actin polymer-
ization. Thus internalization, like pore formation and trans-
location, is inhibited by the GAP activity of YopE, and by
treatment with cytochalasin D [4,18]. With this in mind, we
investigated whether invasin or YadA-mediated adhesion to b1
integrin receptors is required for efﬁcient pore formation and
translocation. We created a yopEHJ,yadA,inv mutant strain,
designated YP50, and the corresponding YopB-deﬁcient
mutant YP51 (Table 1). To provide a means of adhesion, a
pAY66 plasmid, constitutively expressing pH6 antigen (Table
1), was inserted into YP50 and YP51. The pH6 antigen is a
ﬁmbrial adhesin that can mediate adhesion of Yersina to
epithelial cells but does not induce bacterial uptake [27]. The
defect in internalization of YP50/pAY66 and YP51/pAY66 was
conﬁrmed by immunoﬂuorescence (not shown, see below). To
corroborate that pH6 ag can substitute invasin or YadA for
adherence, we evaluated the binding ability of the YP50/pAY66
strain after one hour infection by immunoﬂuorescence. We
found that YP50/pAY66 adhered to HeLa cells at levels similar
to yopEHJ (YP27) expressing invasin or YadA (not shown).
YP50/pAY66 strain was compared to the YP27 strain for the
ability to induce pore formation. Surprisingly, YP50/pAY66
caused lower levels of LDH release than YP27 (Figure 3A),
and was defective for promoting uptake of EthD-2 by infected
HeLa cells (not shown). As expected, infection with the
corresponding yopB mutant YP51/pAY66 resulted in even
lower levels of LDH release. Ectopic expression of YadA in
the YP50 strain rescued LDH release, indicating that
interaction with b1 integrin receptors is critical for pore
formation. To rule out that the impairment of the inv,yadA,
pH6 antigen-expressing mutant to cause pore formation was
due to a defective activation of the TTSS, we tested the ability
of YP50/pAY66 to induce IL-8 production, NFjB activation,
and ERK phosphorylation. We have previously found that the
ability to stimulate these pro-inﬂammatory signals requires
YopB but is independent of pore formation [16]. As shown in
Figure 3B, after 5 hours infection, IL-8 production was not
considerably reduced by the absence of invasin or YadA.
Similarly, YopB-dependent activation of NFjB and ERK,
measured at 1 hour-post infection, did not require invasin or
YadA (Figure S3), suggesting that YopB is able to stimulate
cell responses whether adhesion is provided by invasin/YadA
or by pH6 antigen. Collectively, these results indicate that
interaction of the bacteria with b1 integrin receptors is
required to stimulate pore formation.
To investigate whether engagement of b1 integrin receptors
is also needed for the translocation process, we tested the
ability of a yadA,inv mutant to translocate YopE. To this end, we
replaced the mutated yopE by the wild type yopE gene in YP50/
Table 1. Characteristics of the Strains and Plasmids Used in This
Study
Strain or Plasmid Characteristics Reference
YP126 Wild type Y. pseudotuberculosis derived




























YP54/pAY66 yopEwt replaced yopE::kan in YP50/pAY66 This work
YPIII P







pCGT Expression plasmid with T7-tag [55]
pCGTRacN17 Expresses a T7 tagged dominant-negative
Rac
[56]
pTAT-C3 His tagged TAT-C3 [55]
pAY66 LacP::psaABC, expresses pH6 antigen
under control of Lac promoter
[27]
pYadA pMMB67HE YadA [52]
doi:10.1371/journal.ppat.0040003.t001
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ability to cause pore formation, the inv,yadA, pH6 antigen-
expressing mutant translocated undetectable levels of YopE
(Figure 3C). Consequent with these ﬁndings, YP54/pAY66
induced cell rounding at a much slower rate than the wild type
YP126 (Figure 3D, compare YP126 and YP54/pAY66 after 30
min infection). Efﬁcient YopE translocation was restored when
YadA was expressed in YP54 (Figure 3C). This suggests that the
interaction of Y. pseudotuberculosis with b1 integrin receptors is
required for an effective translocation process.
A Y. pseudotuberculosis Invasin D911E Mutant Is Deficient
in Pore Formation and Translocation
As invasin and YadA promote both binding to b1 integrins
and stimulation of signaling by this receptor, we used a
mutant that is competent for binding to b1 integrins but
defective in signaling, to establish which activity was
important for pore formation and translocation. A single
amino acid substitution, D911E, in the invasin protein retains
binding to host cells, but results in low afﬁnity interaction
with b1 integrins, poor receptor clustering, and a consequent
defect in signaling and internalization [28]. Thus, we assessed
the ability of YP50invD911E and YP54invD911E to induce
pore formation and to mediate YopE translocation, respec-
tively. Although infection with YP50invD911E resulted in
robust IL-8 production (Figure 3B), the levels of LDH release
by cells infected with YP50invD911E were as low as those cells
infected with the strains that adhere via pH6 antigen (Figure
3A). Similarly, YP54invD911E was impaired in YopE trans-
location (Figures 3C and 3D). We ruled out that the defect in
translocation was a consequence of fewer YP54invD911E
bacteria binding to Hela cells. Thus, immunoﬂuorescence
Figure 3. Effect of Invasin and yadA Inactivation on Pore Formation and Translocation
HeLa cells were infected with Y. pseudotuberculosis strains yopEHJ (YP27), yopEHJB (YP29), yopEHJ,yadA,inv/ppsaABC (YP50/pAY66), yopEHJB,yadA,inv/
ppsaABC (YP51/pAY66), yopEHJ,yadA,inv/pMMB67HE YadA (YP50/pYadA), or yopEHJ,yadA,invD911E (YP50invD911E). LDH was determined in the culture
supernatants as described in Figure 1 (A). Culture supernatants were collected from triplicate wells 5h post infection and assayed using an IL-8 ELISA
(Antigenix America) (B). Y. pseudotuberculosis wild type (YP126), yopB mutant (YP18), yopHJ,yadA,inv/psaABC (YP54/pAY66), yopHJ,yadA,inv/pMMB67HE
YadA (YP54/pYadA), or yopHJ,yadA,invD911E (YP54invD911E) strains were used to infect HeLa cells for 2 hours, and translocated YopE was analyzed by
immunoblotting as described in Figure 2. Soluble fractions correspond to translocated YopE, and insoluble fractions correspond to bacteria-associated
YopE (C). YopE-mediated cytotoxicity was analyzed by phase contrast microscopy at 15, 30 and 60 min post infection in cells infected with wild type
(YP126) strain, YP54/pAY66 or YP54invD911 (D).
doi:10.1371/journal.ppat.0040003.g003
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infected cells had a mean of 16.6 associated bacteria/cell, only
slightly lower than the invasin-expressing strain (19.7 bacteria/
cell, Figure S4A). Moreover, a two-fold increase in the
multiplicity of infection of YP54/pAY66 and YP54invD911E
did not result in higher levels of YopE translocation (Figure
S4B). We conclude that efﬁcient translocation and pore
formation involve high afﬁnity binding to b1i n t e g r i n
receptors.
To examine the binding characteristics of the inv/yadA
mutant we performed transmission electron microscopy in
thin section of infected HeLa cells. As expected, yopEHJ
(YP27) bacteria were either internalized, or were in the
process of being engulfed, and tightly attached to the host
cells (Figure S5A). On the other hand, yopEHJ,yadA,inv/psaABC
(YP50/pAY66) were almost exclusively extracellular and
seemed to bind more loosely (Figure S5B). Adhesion
mediated by invD911E differed from that imparted by wild
type invasin (Figure S5A and S5C). This suggests that lack of
high afﬁnity binding to b1 integrin receptors not only
impairs b1 integrin signaling, but might also affect the way
the bacteria interacts with the host cell.
Selective Inhibition of Src Family of Tyrosine Kinases
Impairs Effective Yop Translocation
Stimulation of signaling through b1 integrins receptor by
invasin and YadA involves tyrosine phosphorylation of a
series of signaling proteins. Src is a key signal-transducing
protein kinase in the b1 signaling pathway leading to
internalization. To determine if Src activation plays a role
in Yop translocation, we tested the effect of a selective
inhibitor of Src family kinases, PP2, on infected cells. Pre-
treatment of cells for 1 hour with 10lM PP2 efﬁciently
inhibited b1 integrin signaling pathway leading to bacterial
internalization without decreasing bacterial adherence (not
shown). Interestingly, pore formation and YopE translocation
were also impaired in PP2-treated cells (Figures 4A and B).
These data indicate that Src activation stimulates trans-
location, and point toward a role of b1 integrin signaling in
the Yop translocation.
Internalization Is Not Required for Pore Formation or
Translocation
Invasin triggered-Rac1 signaling pathways downstream of
Tyr phosphorylation are essential for Yersinia uptake [15]. We
made use of a speciﬁc Rac1 inhibitor to determine whether
b1 integrin–mediated internalization was required for efﬁ-
cient pore formation and translocation. NSC23766 is a small
chemical compound reported to speciﬁcally block the bind-
ing between Rac1 and its exclusive GEFs [29]. We tested the
effect of the Rac1 inhibitor by pre-treating HeLa cells for 6h
with 100lM of NSC23766 in DMEM with 5% serum. As
expected, bacterial uptake was impaired by treatment with
the Rac inhibitor, with the number of yopEHJ (YP27) bacteria
internalized by NSC23766-treated cells being comparable to
that of the uptake-deﬁcient yopEHJ,yadA,inv (YP50/pAY66)
strain (Figure 5A). NSC23766 treatment was also found to
inhibit formation of phagosomes, as the number of actin cups
was reduced more than 5 fold in the presence of the inhibitor
(Figure S6). We further excluded any effect of NSC23766
treatment on the number of cell-associated bacteria by
immunoﬂuorescence (not shown). Transmission electron
microscopy of thin sections also conﬁrmed that NSC23766
inhibited bacterial uptake by, but not association to HeLa
cells (Figure S5D). Importantly, treatment with NSC23766 did
not reduce pore formation or Yop translocation (Figures 5B
and 5C, respectively). These results indicate that bacterial
internalization is not required for pore formation or trans-
location.
To validate our ﬁndings using the Rac1 inhibitor, we
Figure 4. Effect of Src Kinase Inhibitor PP2 on Pore Formation and Yop Translocation
HeLa cells were exposed to 10 lM PP2 in DMSO or to DMSO alone one hour prior to infection. HeLa cells infected with YP27 (yopEHJ) or YP29 (yopEHJB)
were assessed for pore formation as indicated for Figure 1 A. Wild type (YP126) and yopB mutant (YP18) were used to infect treated HeLa cells for 2
hours. YopE translocation was determined as described in Figure legend 2B.
doi:10.1371/journal.ppat.0040003.g004
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transfected cells with a eukaryotic expression plasmid coding
for a T7 tagged-RacN17 (pCGTRacN17) and we evaluated
whether pore formation was impaired in transfected cells.
Overexpression of Rac1N17 (green cells) did not prevent pore
formation as shown by the uptake of the impermeable dye
EthD-2 (Figures S7A and S7B). Altogether, these data provide
evidence indicating that neither bacterial internalization, nor
Rac1 activation, play a major role in the processes that govern
pore formation and Yop translocation.
Rho Inhibitor C3 Blocks Pore Formation and Inhibits Yop
Translocation
C3 is an ADP-ribosylating protein of Clostridium botulinum
that speciﬁcally inhibits Rho A, B and C. A recombinant cell-
permeable form of C3 toxin (TAT-C3) was produced in E. coli
and puriﬁed as described in Material and Methods. Four
hours before infection, HeLa cells were treated with 10, 20,
and 40lg/ml of TAT-C3 in serum-free medium, or with
serum-free medium alone. C3 has been previously shown to
increase Y. pseudotuberculosis uptake in COS-1 cells [30]; in our
experimental model, pretreatment of cells with 20lg/ml TAT-
C3 did not affect bacterial adhesion or internalization
considerably (Figures S8A and S8B, respectively). Interest-
ingly, TAT-C3 treatment of cells infected with the pore
forming strain yopEHJ (YP27) inhibited LDH release in a dose-
dependent manner (Figure 6A). The effect of Rho inhibition
on translocation was also substantial (Figure 6B). In various
experiments, treatment with different batches of puriﬁed
TAT-C3 (40lg/ml) reduced YopE delivery into wild type-
infected cells, by 40% to 75 %. Similar results were obtained
when we tested the effect of C3 treatment on YopH
translocation (Figure 6B), indicating that the requirement
of Rho for translocation is not a phenomenon restricted to
YopE delivery.
To test whether actin polymerization required for pore
formation and translocation was dependent on Rho, we
analyzed the effect of C3 on the induction of actin polymer-
ization around the bacteria [18]. We found that the number
of YopB-dependent actin halos was considerably reduced in
the presence of C3 (Figure 6C).
Rho Is Activated by a Mechanism That Requires YopB and
Invasin/YadA-Mediated Signaling
To determine whether Rho is activated by infection with Y.
pseudotuberculosis, we infected HeLa cells with strain yopEHJ
(YP27) for 5, 10, 15 and 20 min and we analyzed the amount
of active Rho (GTP-Rho) in the cell lysates by a GTP-Rho pull-
down assay, as described in Material and Methods. A peak of
Rho activation was detected between 10 and 15 min after
infection (Figure 7A). A 15 min infection period was selected
to test the levels of GTP-Rho induced by infection with
yopEHJ (YP27), yopEHJB (YP29), yopEHJ,yadA,invD911E (YP50/
invD911E), and yopEHJB,yadA,invD911E (YP51/invD911E).
Compared to YP27-infected cells, cells infected with YP29
have reduced amounts of GTP-Rho, indicating that Rho
activation is YopB-dependent (Figure 7B). Low afﬁnity
interaction with b1 integrin receptors by infection with
YP50/ invD911E cause a reduced activation of Rho. However,
YopB-independent Rho activation in YP29-infected cell
lysates was greater than that of cells infected with
YP51invD911E. This small difference, attributed to wild type
invasin or YadA interacting with b1 integrin receptors, was
consistent in three independent experiments. Overall, these
Figure 5. Rac Inactivation Inhibits Bacterial Uptake but Not Pore Formation or Translocation
Hela cells were treated for 6h with Rac inhibitor NSC23766 (100lM) in 5% serum-DMEM, or with 5% serum-DMEM alone. NSC23766-treated and
untreated cells were infected with YP27 (yopEHJ) or the uptake-deficient strain YP50/pAY66 (yopEHJ,yadA,inv/psaABC). The percentage of internalized
bacteria was assessed one hour after infection by double staining immunofluorescence, as described in Material and Methods (A). LDH released by
uninfected cells or by cells infected with YP27 or YP29 (yopEHJB), in the presence or absence of the Rac inhibitor, was assessed as described in Figure 1
(B). The amount of translocated YopE in the cell lysate of cells infected with wild type (YP126) or yopB (YP18) was analyzed by immunoblotting as
described Figure 2 (C).
doi:10.1371/journal.ppat.0040003.g005
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activates Rho by a process that involves YopB and high
afﬁnity interaction with b1 integrin receptors.
Discussion
The TTSS-mediated translocation of bacterial effectors
into host cells is an intricate mechanism that, although
extensively studied, has not been completely unraveled [31].
Here we have found that Y. pseudotuberculosis engages the small
GTPase Rho to control the delivery of effectors to the host
cell. Activation of this signaling pathway is mediated by the
YopB/YopD translocon in cooperation with the high afﬁnity
binding of invasin or YadA to b-1 integrins.
It has been put forward that pore formation and trans-
location of effector Yops into the host cells are not related
processes [19,32]. Pore formation has been recently impli-
cated in mediating a caspase-1 dependent type of cell death
in Salmonella-infected macrophages [21]. Shin and Cornelis
[33] have recently reported that insertion of translocation
pores in macrophages infected with a multi-effector mutant
of Y. enterocolitica triggers activation of caspase-1. Here we
ruled out that in our infection system, YopB/YopD-mediated
pore formation induces caspase-1 dependent cell death.
Thus, amounts of a speciﬁc caspase-1 inhibitor large enough
to block IL-1 b production in macrophages, does not prevent
LDH release in Hela cells. Also, glycine treatment that
efﬁciently prevented cell lysis in Salmonella infected macro-
phages failed to inhibit LDH release in Yersinia-infected HeLa
cells. Based on these ﬁndings, we sustain that in our
experimental system pore formation-induced LDH release
is related to the process of Yop translocation.
Both pore formation and translocation require activation
of small Rho GTPases, as glucosylation of Rho, Rac and Cdc42
by C. difﬁcile toxin ToxB potently inhibits the two processes.
We found that Rac activation is not likely to be involved in
pore formation or translocation. Thus over-expression of a
dominant negative form of Rac does not prevent uptake of
membrane impermeable dyes in cells infected with the pore
forming strain. In line with these results, a speciﬁc Rac
inhibitor, NSC23766, that efﬁciently blocks Rac-mediated
internalization, does not inhibit pore formation or trans-
location. On the other hand, we found that signaling
downstream of Rho is essential for the control of Yops
delivery. Treatment with C. botulinum C3 toxin, that converts
endogenous Rho A, B and C into dominant negative forms
[3], potently down-regulates pore formation and transloca-
tion without affecting bacterial adhesion or internalization
considerably.
The type of host cell processes that Rho proteins regulate
to promote translocation and pore formation most likely
involves actin cytoskeleton rearrangements. Thus treatment
with 2lg/ml actin polymerization inhibitor CD blocks pore
formation [18] and decreases the level of YopE translocation
by more than 60%. In early studies aim at demonstrating that
Yop translocation is mediated by extracellular bacteria, Sory
et al studied the effect of 5lg/ml CD treatment on the delivery
of Yop-cyclase fusion proteins by Y. enterocolitica into murine
Figure 6. TAT-C3 Treatment Inhibits Pore Formation, Actin Halos, and Translocation in HeLa Cells
Hela cells were treated for 4h with 10lg/ml, 20lg/ml, or 40lg/ml TAT-C3 in serum-free DMEM or with serum-free DMEM alone. Cells were infected with
yopEHJ (YP27) or yopEHJB (YP29), in the presence or absence TAT-C3, and LDH released was tested after 3 hours, as described in Figure 1 (A). YopE and
YopH translocation into Hela cells infected with wild type (YP126) or translocation-deficient yopB (YP18) strain, in the presence and absence of TAT-C3,
was analyzed by immunoblotting, as described in Figure 2 (B). Cells seeded on coverslips were treated with 40lg/ml TAT-C3, or left untreated, and
infected with yopEHJ (YP27) or yopEHJB (YP29). After 10 min infection cells were washed and fixed, and subjected to immunofluorescence. Actin was
visualized by staining with Rhodamine–phalloidin. Images were acquired by confocal microscopy. Results were expressed as the percentage of bacteria
inducing a halo of actin polymerization. A minimum of 250 bacteria was counted (C).
doi:10.1371/journal.ppat.0040003.g006
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bacterial uptake (2000 fold inhibition), the authors suggest
that Yop translocation was not sensitive to the action of CD.
However, their results show that CD treatment decreased
YopE-cyclase translocation by 32% and YopH-cyclase by
52%. Using 10 times less CD (0.5lg/ml for 30 min) and using a
strain of Salmonella ectopically expressing YopE, Rosqvist et al
reported that Yop translocation into HeLa cells was notably
decreased [35]. The authors also reported that the same was
observed when YopE was delivered by Y. pseudotuberculosis.
Interestingly, our ﬁndings strongly suggest that actin poly-
merization required for pore formation and translocation is
dependent on Rho, as inhibition of Rho A, B and/or C results
in a decrease of the number of actin halos.
Adhesion of bacteria to host cell is crucial for the
activation of the TTSS. In Y. pseudotuberculosis two main
adhesins, invasin and YadA, mediate tight binding to host
cells by interaction with b1 integrin receptors. Here we show
that in an inv/yadA mutant, constitutive expression of the pH6
antigen confers good adhesion properties to host cells. In
spite of that, we found that such mutants are defective in
pore formation and Yop translocation, suggesting that
interaction with b1 integrin receptors is essential for the
two processes. Mota et al. have shown that a minimal needle
length is required for efﬁcient functioning of the Yersinia
injectisome, and that this length correlates with the length of
the YadA protein [36]. We considered that the attachment
imparted by pH6 antigen in the absence of invasin and YadA,
might not provide that critical length. Our data suggest that
this is not likely to be the case in our experimental system.
First, a Y. pseudotuberculosis strain expressing pH6 antigen is
able to stimulate a YopB-dependent proinﬂammatory re-
sponse, including activation of NFjB and ERK, and produc-
tion of IL-8. Second, a single amino acid substitution in
invasin (invD911E), that is not expected to change its length,
failed to mediate efﬁcient Yop translocation. This mutant
promotes adhesion without inducing receptor clustering and
subsequent b1 integrin-mediated signal transduction. Alto-
gether, these results suggest efﬁcient translocation requires
high afﬁnity binding of b1 integrin receptors and subsequent
activation of signaling. It is still conceivable that, independ-
ent of integrin signaling, tight bacterial adhesion mediated by
high afﬁnity interaction with b1 receptors preconditions
effective translocation. The fact that interfering with b1
integrin signaling by the action of a Src inhibitor impairs
efﬁcient translocation, would argue against that idea. Still, we
cannot discard the possibility that Src activity might also be
required for YopB/D-dependent Rho activation.
We predict that upon integrin clustering, RhoA could be
recruited and generate a signal that polymerizes actin. It is
well documented that invasin engagement of b1 integrin
receptors triggers Rac1-mediated signals that induce bacte-
rial internalization into epithelial cells [15]. This Rac1-
mediated mechanism involves Arp2/3, PIP 4,5 and capping-
proteins [30]. Results from our GTP-Rho pull down assays
suggest that bacteria producing invasin and YadA (YP29) can
also mediate Rho activation in a YopB-independent manner.
There are further evidences in the literature that engagement
of b1 integrin receptors can stimulate RhoA activation. Wong
and Isberg have shown that RhoA is recruited at the nascent
phagosome in Cos1 cells infected with a yopE yopT mutant of Y
pseudotuberculosis [26]. Werner et al have reported that
interaction of invasin-coated beads with a5b1 integrin in
synovial ﬁbroblast results in beads uptake by a process that is
RhoA-dependent [37]. Also, activation of RhoA by engage-
ment of a5b1 integrins by Ipa invasins has been implicated in
the internalization of Shigella to HeLa cells [38,39]. Alter-
natively, b1 integrin may indirectly facilitate Rho activation
by a focal adhesion kinase (FAK) -dependent pathway. Such a
mechanism of Rho activation has been described for the
regulation of microtubules stabilization at the leading edge of
mouse ﬁbroblasts [40], and involves targeting of Rho to GM1-
rich domains in the plasma membrane, where it can interact
with downstream effectors.
We envision a model in which high afﬁnity binding to b1
integrin receptors, in addition to stimulating Rac activation,
triggers Rho activation (Figure 8). Subsequently, YopB/D
insertion into the plasma membrane stimulates increased
Figure 7. Rho Activation Requires YopB and High Affinity Interaction of the Bacteria with b1 Integrin
HeLa cells grown in 10cm diameter dishes were infected with yopEHJ (YP27) for 5, 10, 15, and 20 min. GTP-bound active Rho was pulled-down from cell
lysates with a GST-fusion protein harboring the Rho binding domain of rhotekin. The precipitates were subjected to immunobloting using an anti-Rho
monoclonal antibody. The amount of total Rho was determined in a 20ll aliquot (approx. 3%) of the cell lysates. Results were expressed in arbitrary
units (AU) as the ratio between pulled-down GTP-Rho and total Rho (A). HeLa cells were left uninfected or were infected with yopEHJ (YP27), yopEHJB
(YP29), yopEHJ,yadA,invD911E (YP50invD911E), and yopEHJB,yadA,invD911E (YP51invD911E) for 15min. The amount of GTP-Rho in each of the lysates
was determined as described above (B).
doi:10.1371/journal.ppat.0040003.g007
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stimulates Yop translocation. A central question is how Rho
activation regulates Yop translocation. We hypothesize that
Rho signaling induces changes in the host cell, such as actin
polymerization, that are required for an efﬁcient trans-
location process. One possibility is that, cell molecules
present in specialized membrane microdomains, such as lipid
rafts, are required for efﬁcient translocation. These mem-
brane microdomains would be recruited at the site of
bacteria-host cell contact, as a result of Rho GTPases
activation and actin polymerization. More injectisomes could
then interact with lipid rafts at the site of bacteria, and more
effector Yops would be translocated. Once proper amounts of
Yops are delivered into the host cell, the process would be
shut down to avoid further cell damage caused by excessive
signaling. We based our hypothesis, in part, on the fact that
Salmonella and Shigella-YopB homologues bind to cholesterol
[41], and that lipid raft are required for translocation in
Salmonella, Shigella and EPEC [41]. Interestingly, actin poly-
merization and Rho GTPases activation have been shown to
be involved in lipid raft clustering in B cells [42], T cells [43]
and NK cells [44] .
Why is Rho-dependent, but not Rac-dependent, actin
polymerization required for translocation? Rho GTPases
transmit signals that control the formation of distinct
cytoskeletal structures through the interaction with different
nucleating machineries. Cdc42 and Rac mediate nucleation of
branched actin ﬁlaments through the Arp2/3 protein com-
plex, leading to lamellipodia formation. On the other hand,
Rho proteins stimulate unbranched actin ﬁlaments forma-
tion, such as those in stress ﬁbers, via interaction with formins.
It could be speculated that only F-actin structures generated
by formins are important for translocation. The effect of the
expression of dominant negative mutants of the formin
mDia1 on translocation will be investigated in future studies.
Findings from two studies that investigate translocation of
TTSS effector proteins by Salmonella and Shigella in real time
[45,46] indicate that effector translocation occurs right after
host cell contact, with a half maximal rate of about 4 min. In
our experimental model we detect the strongest Rho
activation after 10 to 15 min infection with a YopEHJ bacteria.
This is probably due to accumulation of GTP-Rho in the
absence of the Rho inhibitors YopE and YopT. The decrease
in the levels of GTP-Rho after 15 min is presumably due by
the action of endogenous GAPs. We envision that during
infection with wild type bacteria, the kinetics of Rho
activation would be much faster. Translocation of Salmonella
SipA and SopE, and Shigella IpaC were found to follow a
Figure 8. Model for the Requirement of Rho Activation and Actin Polymerization for Pore Formation and Efficient Translocation
Upon binding of invasin or YadA to b1 integrin receptor, TTSS is activated, and YopB/D insert in the host cell plasma membrane (in cholesterol-rich
domains present in the lipid rafts). YadA/invasin-mediated high affinity binding to b1 integrin receptor activates Rac, and Rho. Membrane-associated
YopB/D, stimulates signaling that cooperates with b1 integrins to fully activate Rho. Actin polymerization, resulting from Rho activation, presumably
induces lipid raft clustering at the site of the bacterial contact. More injectisomes can then interact with lipid rafts, and more effector Yops are
translocated. As soon as enough Yops are translocated, the process is reverted by the inhibitory action of YopE and YopT on the Rho GTPases. Depicted
are the inhibitory action on pore formation and translocation of an invasin mutant that binds to b1 integrin with low affinity (InvD911E), the Src
inhibitor PP2, the RhoGTPases pan inhibitor ToxB, the specific Rho inhibitor C3, the specific Rac inhibitor NSC23766, and the actin polymerization
inhibitor cytochalasin D.
doi:10.1371/journal.ppat.0040003.g008
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secretion kinetics curves seemed to vary at different time
points, suggesting that the speed of injection changes during
the course of the translocation process resembling a slow-
fast-slow type of mechanism. This type of translocation
kinetic is what we would expect in our model.
How does our model ﬁt with the mechanism of Yop
translocation in Y. pestis? Although closely related to Y.
pseudotuberculosis, Y. pestis lacks invasin and YadA. Unless Y.
pestis has yet-unidentiﬁed adhesins that interact with b1
integrin receptors, we envision that the bacteria would
activate Rho only by the stimulus elicited by YopB/D. In this
situation, Rho activation would be limited, and therefore, one
should expect that Y. pestis would be less effective for Yop
translocation. A recent report suggests that, in macrophages,
Y. pestis translocate less YopJ than a Y. enterocolitica strain
expressing invasin and YadA [47]. However, in this report the
authors suggest that this is most likely due to a difference
between the YopJ protein from the two Yersinia species. We
have preliminary results suggesting that Y. pestis deliver much
less YopE in HeLa cells than Y. pseudotuberculosis.
It has been proposed that, because bacterial effectors are
directly injected within cell cytosol, the TTSS does not need
to trigger signals through cell surface receptor [48]. Our data
suggest that, although not essential, signal stimulated by
engagement of b1 integrin receptors greatly enhances Yop
translocation.
Materials and Methods
Bacterial strains. The wild-type serogroup III Y. pseudotuberculosis
strain YP126 [49], and the mutants derived thereof are shown in
Table 1. YP126 and its derivatives carry a naturally occurring deletion
in virulence plasmid that inactivates the yopT gene and are thus
devoid of YopT activity [50].
Strain construction. YP202/YP29 (yopEHJB,inv) was constructed by
inserting the virulence plasmid of YP29 into a plasmid cured, inv::kan
strain (YP202, Table 1). To create YP50 (yopEHJ,yadA,inv) and the
corresponding YopB-deﬁcient mutant (YP51), the wild type yadA gene
in YP202/pYP27 (yopEHJ,inv) and in YP202/pYP29 (yopEHJB,inv),
respectively, was replaced by yadA containing a frame shift deletion
(yadAfs), as follows. yadAfs was constructed by amplifying yadA with
primer YadA F1 (59-CCC GGG TTT GTA GTG GGC TGA CTC CGA
C-39) and B1 (59’-GGC TGA ACT GGC TAA ACC TTT G-39). The yadA
DNA fragment was subsequently blunt-cloned into pETBlue (Nova-
gen). QuikChange Site-Directed mutagenesis (Stratagene) was used to
create the frame-shift and generate a SphI restriction site using
primers F2 (59-CA CAA GGT CCA GAA AAA AAA GAG CAT GCA
TTA GCA GAA GCA ATA C-39), and B2 (59-GTA TTG CTT CTG CTA
ATG CAT GCT CTT TTT TTT CTG GAC CTT GTG-39). Plasmid
pETBlue-yadAfs was digested with XmaI and subcloned into the
suicide plasmid pSB890 containing sacB and Tet
R genes [51].
pSB890yadAfs was then introduced into S17-kpir and conjugated into
Cam
R YP202/pYV27 and YP202/pYV29. Tet
R Cam
R colonies were
grown for several generations in the absence of Tet and were selected




were screened for yadAfs by PCR using primers YadA F1 and B1,
followed by SphI-digestion of the ampliﬁed yadA fragment. A plasmid
constitutively expressing pH6 antigen ﬁmbriae, pAY66 (LacP::
psaABC, Table1), a gift from R. Isberg (Tufts University), was inserted
into YP50 and YP51 by electroporation. To create YP54/pAY66
(yopHJ,inv,yadA/psaABC), we replaced yopE::kan in YP50/pAY66 by wild
type yopE, by allelic exchange using suicide plasmid pSB890YopE,
essentially as described above. To construct YP50invD911E (yopEHJ,
yadA,invD911E) and YP51invD911E (yopEHJB,yadA,invD911E), the
virulence plasmid from YP50 and YP51 were introduced into YPIII
P
- invD911E (Table 1, gift from R. Isberg ) by electroporation. To
create YP54invD911E, we replaced yopE::kan in YP50invD911E by wild
type yopE, by allelic exchange using pSB890yopE as described above.
Plasmid pMMB67HEYadA (pYadA) [52], was inserted into YP50 and
YP54 by electroporation.
Cell culture and infection conditions. HeLa cells were cultured as
previously described [16]. For experiments carried out in the
presence of inhibitors, cells were pre-incubated with 50–100 lM
Ac-YVAD-cmk (Calbiochem), 5mM Glycine (Roche), 40ng/ml Clostri-
dium difﬁcile ToxB (Calbiochem), 3.9 lM( 2 lg/ml) cytochalasin D
(Sigma), 10 lM PP2 (Sigma), 100 lM NSC23766 (Calbiochem), 10, 20,
or 40 lg/ml TAT-C3. Bacteria used for infections were grown in
Luria-Bertani (LB) broth either under conditions that stimulate (low
Ca
2þat 37 8C) or repress (high Ca
2þat 28 8C) Yop expression [4,51], at
a multiplicity of infection of 50 to 100. The plates containing the
infected cells were centrifuged for 5 min at 700 rpm and incubated at
37 8C with 5% CO2 for different periods of time to allow bacterial-
host cell interaction.
Uptake of impermeable dye ethidium homodimer-2. Cells cultured
in 24-well plates with coverslips were infected for 3 h with bacteria
grown under low calcium conditions. A green ﬂuorescent membrane-
permeable nucleic acid stain (SYTO10) and a red membrane-
impermeable nucleic acid dye that label only cells with compromised
membranes, ethidium homodimer-2 (EthD-2) were provided in the
DEAD-LIVE kit (Invitrogen). After washing, a mixture of the two dyes
was added to the wells and incubated in the darkness for 15 min at
room temperature. Cells were then washed and ﬁxed with 2%
paraformaldheyde in PBS. Coverslips were mounted with 8 llo f
ProLong mounting medium (Molecular Probes) and slides were then
examined by immunoﬂuorescence microscopy.
LDH assay. Samples of culture media from wells containing
infected cells were collected 3 h post infection. Levels of LDH were
assayed using the CytoTox 96 assay kit (Promega) as previously
described [16].
Yop translocation assay. HeLa cells cultured in 6 cm
2 dishes were
infected with bacteria grown at high Ca
2þ conditions. Infected cells
were lysed with 0.2 ml of cold 1% Triton X-100 buffer as described
[4]. Soluble and insoluble fractions were subjected to immunoblotting
using an afﬁnity puriﬁed polyclonal anti-YopE and anti YopH
antibodies, as described previously [4]. Anti-b actin antibody was
used as a loading control. Anti-rabbit antibodies conjugated with
IR800 or IR680 were used as secondary antibodies, and the infrared
signal was detected using an infrared imaging system (Odyssey, LI-
COR). Quantiﬁcation of a ﬂuorescent signal is more accurate than
that generated by chemiluminescence because its intensity is not
time-dependent. The bands intensities were calculated using the
software provided by the Odyssey system, and the values were
expressed as the YopE/b-actin ratio and plotted on a graph.
IL-8 assay. Supernatants of infected HeLa cells were assayed for IL-
8 production by ELISA (Antigenix America) ﬁve h after infection, as
previously described [16]. Values obtained from triplicate wells were
assayed in duplicate and averaged.
Bacterial uptake assay. HeLa cells were seeded onto glass coverslips
at 10
5 cells per well in a 24-well tissue culture plate 24 h before
infection. Cells were infected with bacteria at a calculated MOI of 50:1.
After a brief centrifugation step (5 min at 100 g), the plates were
incubated for 30 min at 37 8C in a 5% CO2 incubator. A double-label
immunoﬂuorescence assay was used to differentiate between extra-
cellular and intracellular cell-associated bacteria as previously
described [4]. Coverslips containing infected cells were washed with
PBS and ﬁxed in 2% paraformaldehyde for 15 min. The washed
coverslips were incubated with polyclonal anti-Yersinia antibody SB349
(diluted 1:1000) for 40 min to stain extracellular bacteria. Washed
coverslips were incubated for 40 min with FITC-conjugated goat anti-
rabbit IgG diluted 1:250. After washing, cells were permeabilized with
0.2% Triton X-100 for 10 min. Coverslips were washed and incubated
with SB349 (1:1,000) for 40 min to label both extracellular and
intracellular bacteria. Samples were then washed and incubated for 40
min with TRITC-conjugated goat anti-rabbit IgG (1:300). All anti-
bodies were diluted in PBS containing 3% BSA, and washes were
conducted three times for 5 min with PBS containing 1% BSA.
Coverslips were washed with PBS before mounting and examined by
immunoﬂuorescence microscopy. The percentage uptake was calcu-
lated as the number of [intracellular bacteria (red)/total bacteria
(green and red)] 3 100.
Staining of actin cups. The effect of Rac and Rho inhibitors on the
formation of actin cups was tested in Hela cells seeded on coverslips.
To inhibit Rac, the cells were treated for 6 h with NSC23766 (100lM)
in 5% serum-DMEM, or 5% serum-DMEM alone. To inhibit RhoA, B
and C, TATC3 (40 lg/ml) was added to the cells in serum free medium
for 4 h, and control cells were incubated in serum free conditions for
the same time. Hela cells were then infected for 10–15 min, washed
and ﬁxed as described above for the bacterial uptake assay. Double
immunoﬂuorescence was performed as detailed above for the
bacterial uptake assay, with the addition of 50 U/ml of Rhodamine
Phalloidin (Molecular Probes) together with the last secondary
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The percentage of bacteria (extracellular and intracellular) sur-
rounded by an ‘‘actin halo’’ was calculated by counting a minimum of
150 bacteria.
Puriﬁcation of His-TAT-C3. Plasmid pTAT–C3 (a gift from Dafna
Bar Sagi, Stony Brook University, NY) was introduced into E. coli
(strain BL21), and His-tagged-TAT–C3 protein were expressed by
IPTG induction (1 mM IPTG, 4 h). Recombinant His-TAT–C3 was
extracted from E. coli BL21 strain by sonication, and puriﬁed by fast
protein liquid chromatography (FPLC), as follows. The supernatant
of the cell lysate was injected onto a Hi-trap Ni-column (Pharmacia
Co.). The column was washed with a 5 mM imidazole buffer solution
and eluted using a gradient concentration of 1M imidazole buffer.
After dialysis against PBS/0.5M NaCl, the purity of each TAT–C3
preparation was determined on polyacrylamide gels stained with
Coomassie blue.
Pull-down assay for GTP-Rho. Cells were seeded in 10 cm dishes at
90% conﬂuency and were left uninfected or were infected at a
moi:100 for different time periods. Cells were lysed in lysis buffer
(Upstate, Rho activation assay) containing 10% glycerol, and protease
inhibitor (Roche). Cell lysates were clariﬁed by centrifugation at
13,000 rpm at 4 8C for 10 min, and the supernatants were incubated
with 30 lg of GST fused to the Rho binding domain of rhotekin
bound to with glutathione beads, at 4 8C for 45 min. The beads were
washed twice with lysis buffer and subjected to SDS-polyacrylamide
gel electrophoresis on a 12% gel. Bound RhoA was detected by
Western blot using a monoclonal antibody against RhoA (Santa Cruz
Biotechnology).
Supporting Information
Figure S1. Caspase-1 Inhibitor YVAD Effectively Inhibits YopB-
Mediated IL-1 b Production
J774A.1 cells were treated with YVAD as described in Figure 1, and
left uninfected or infected with Y. pseudotuberculosis strains yopEHJ
(YP27) or yopEHJB (YP29). Culture supernatants were collected from
triplicate wells 6 h post infection and assayed using an IL-1 b ELISA
(R&D Systems).
Found at doi:10.1371/journal.ppat.0040003.sg001 (18 KB PDF).
Figure S2. Effect of ToxB Treatment on Bacterial Adherence to HeLa
Cells
ToxB-treated or untreated cells on coverslips were infected with wild
type (YP126) for 1 h and subjected to immunoﬂuorescence to stain
bacteria. The mean number of cell-associated bacteria and the
standard deviation of the mean, in both conditions, were calculated
by counting a minimum of 76 HeLa cells.
Found at doi:10.1371/journal.ppat.0040003.sg002 (20 KB PDF).
Figure S3. NFjB and MAPK Activation
HeLa cells were either left uninfected or infected with strains yopEHJ
(YP27), yopEHJB (YP29), yopEHJ,yadA,inv/ppsaABC (YP50/pAY66), or
yopEHJB,yadA,inv/ppsaABC, (YP51/pAY66) for 1 h. Cells were lysed and
soluble fractions of equivalent protein concentration were separated
by SDS–PAGE and analyzed by immunoblotting with antibodies
against IjBa, or the phosphorylated forms of ERK. Degradation of
NFjB’s inhibitor IjBa indirectly determines NFjB activation.
Found at doi:10.1371/journal.ppat.0040003.sg003 (42 KB PDF).
Figure S4. Y. pseudotuberculosis Expressing Invasin D911E Retains Most
of Its Adhesive Capacity
HeLa cells on coverslips were infected with Y. pseudotuberculosis strains
yopEHJ (YP27) or yopEHJ,yadA,invD911E (YP50invD911E) for 1 h, and
subjected to immunoﬂuorescence. The mean number of cell-
associated bacteria and the standard deviation of the mean was
calculated by counting a minimum of 50 cells (A). Increasing the
number of cell-associated yadA,inv bacteria does not ameliorate poor
translocation. Y. pseudotuberculosis wild type (YP126), yopB mutant
(YP18), yopHJ,yadA,inv/ppsaABC (YP54/pAY66), or yopHJ,yadA,invD911E
(YP54invD911E) strains were used to infect HeLa cells for 2 h at
multiplicity of infection 100 or 200. Translocated YopE was analyzed
by immunoblotting as described in Figure 2 (B).
Found at doi:10.1371/journal.ppat.0040003.sg004 (47 KB PDF).
Figure S5. Transmission Electron Microscopy Showing Binding of
Y.pseudotuberculosis to HeLa Cells
HeLa cells grown on vinyl micro slides were either untreated and
infected with Y. pseudotuberculosis strains yopEHJ (YP27) (A), yopEHJ,ya-
dA,inv/psaABC (YP50/pAY66) (B), or yopEHJ,yadA,invD911E
(YP50invD911E) (C), or treated for 6 h with 100 lM NSC23766 Rac
inhibitor and infected with YP27 (D). Coverslips were washed, ﬁxed
with 2.5% glutaraldehyde and processed for thin section transmission
electron microscopy by the Central Microscopy Imaging Center at
Stony Brook University. Digital images of the thin sections were
acquired using a FEI BioTwinG2 transmission electron microscope.
Found at doi:10.1371/journal.ppat.0040003.sg005 (3.6 MB PDF).
Figure S6. Rac Inactivation Inhibits Formation of Nascent Phag-
osomes
Hela cells were treated for 6 h with Rac inhibitor NSC23766 (100 lM)
in 5% serum-DMEM, or with 5% serum-DMEM alone, and infected
with YP27 (yopEHJ). The percentage of bacteria associated with actin
cups was assessed 15 min after infection by double staining
immunoﬂuorescence, as described in Material and Methods. A
minimum of 150 bacteria were counted (A). Fluorescence image
showing actin cups. The image is a projection of several 0.8 lmZ
stacks confocal microscopy pictures from HeLa cells infected with
YP27 (yopEHJ). White arrows indicate bacteria (blue) inducing a ring
of actin polymerization (red) (B).
Found at doi:10.1371/journal.ppat.0040003.sg006 (1.0 MB PDF).
Figure S7. Analysis of Pore Formation by Immunoﬂuorescence in
Cells Overexpressing a Dominant Negative Form of Rac
Hela cells were transiently transfected with pCGTN17Rac 24h prior
to infection with yopEHJ (YP27) strain. Infected cells were ﬁrst stained
with ethidium homodimer-2 (EthD2) to detect cells that have
undergone pore formation. Cells were then ﬁxed and subjected to
immunoﬂuorescence to detect T7-N17Rac using anti-T7 antibody,
and anti-mouse FITC as primary and secondary antibodies, respec-
tively (A). The percentage of cells that were permeable to the EthD-2
dye was compared among transfected and nontransfected cells. A
total of 50 cells were counted (B).
Found at doi:10.1371/journal.ppat.0040003.sg007 (62 KB PDF).
Figure S8. Rho Inhibition Does Not Impair Bacterial Association to,
or Bacterial Internalization Into HeLa Cells
Hela cells were treated for 4 h with 40 lg/ml TAT-C3 in serum-free
DMEM or with serum-free DMEM alone. TAT-C3-treated and
untreated cells were infected with yopEHJ (YP27). The number of
cell-associated bacteria (A), and internalized bacteria (B) was
determined one h after infection by immunoﬂuorescence, as
described in Material and Methods.
Found at doi:10.1371/journal.ppat.0040003.sg008 (16 KB PDF)
Text S1. Supplementary Methods
Found at doi:10.1371/journal.ppat.0040003.sd001 (23 KB DOC).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html) ac-
cession number for invasin is M17448.
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